Article Text

PDF
AB0682 The incidence rate of inflammatory myopathies in slovenia
  1. Ž Rotar1,
  2. A Hočevar1,
  3. M Krošel1,
  4. S Praprotnik1,
  5. M Tomšič1,2
  1. 1Department of Rheumatology, University Medical Centre Ljubljana
  2. 2Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia

Abstract

Background Annual incidence rates of inflammatory myopathies (IM) vary widely from 1.16–19.0 per 106 of adults.1 Our aim was to, for the first time, determine the incidence rate of IM in our population.

Objectives To determine the incidence rate of IM in our population.

Methods We retrospectively collected incident cases of IM from 1 January 2005 to 31 December 2016 at our department of rheumatology which is a part of an integrated secondary/tertiary university teaching hospital that is the only referral center for two well defined regions representing roughly a third of the national adult population. Tertiary cases are referred to our department from the entire country. We identified the cases by searching the electronic patient records (PRs) for ICD-10 codes M05, M33–35, M60, G73.7, G72.4. The paper and electronic PRs were scrutinized to assess clinical, laboratory and histopathological data. Descriptive statistics was used to describe our group of patients. The adult population size of the two regions served by our department was obtained from the national statistics institute database. The annual incidence rate for IM was then calculated.

Results During the 12-year observation period we identified 117 new cases of IM from a well-defined adult white Caucasian population aged 18 or above. 38 cases were excluded from analyses since they were referred to our department from outside the two regions we serve on the secondary and tertiary level. Thus, we analyzed 79 cases of IM (63% female; median (IQR) age 67 (55–75) years; 44% ever smokers). The median time to diagnosis was 5 (IQR 3–12) months. We diagnosed 29% patients with dermatomyositis, 25% with anti-synthetase syndrome, 18% with polymyositis, 9% with statin induced necrotizing autoimmune myopathy, 9% with concomitant myositis as a part of connective tissue disease, 6% with paraneoplastic myositis, and 4% with undifferentiated myositis. The IM cases were most often diagnosed in the summer months (32.9%), followed by spring (24.1%), fall (22.8%), and winter (20.3%). The clinical and laboratory characteristics at presentation are shown in Table 1. Muscle biopsy was performed in 93% of patients. Notably, patients with swallowing difficulties had more commonly had Raynaud phenomenon (RR 3.7 (95% CI 1.4–9.4), p=0.008).

Conclusions The averaged 12-year annual incidence of IM in the population under study was 9.4 (95% CI 7.5–11.8) per 106 adults.

References

  1. Meyer A, et al. Rheumatology 2015.

References

Disclosure of Interest None declared

Statistics from Altmetric.com

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.